Article10.1007/s00280-015-2830-8
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors
Amita Patnaik,Anthony W. Tolcher,M. Beeram,John Nemunaitis,Glen J. Weiss,Kapil N. Bhalla+7 more-2015-07-25-Cancer Chemotherapy and Pharmacology
65
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
Solid tumorAntagonistPharmacologyMedicineClinical pharmacologyInternal medicineCancerReceptor
Chat
Click to start Chat